% | $
Quotes you view appear here for quick access.

Tekmira Pharmaceuticals Corporation Message Board

  • bocephusbling bocephusbling Jul 11, 2013 7:49 AM Flag

    ALNY TTR program

    Compare the July 16, 2012 ALNY press release on ALN-TTR02 to its press release today on the SubQ non-LNP (so non-TKMR) TTR product. Much more detail in the ALN-TTR02 press release, and knockdown reported as 94%, 14 points higher than the 80% knockdown reported with SubQ. The press release on SubQ does not even say if there were any SAEs even though safety was the primary goal of the trial. One caveat - ALNY says additional data would be presented in September, but if they had more good data wouldn't they release it now? Overall, great day for TKMR.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
3.20+0.10(+3.23%)Oct 25 4:00 PMEDT